Rome, Italy

Paolo De Witt


Average Co-Inventor Count = 2.6

ph-index = 3

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 1982-2003

Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovations of Paolo De Witt

Introduction

Paolo De Witt is a prominent inventor based in Rome, Italy, known for his significant contributions to the field of chemistry. With a total of 12 patents to his name, he has made remarkable advancements in the preparation of chiral compounds, which are essential in the pharmaceutical industry.

Latest Patents

One of his latest patents focuses on the stereospecific hydrolysis of optically active esters. This innovative process offers a more efficient and highly stereospecific method for preparing compounds with the general formula (R)-(I) and absolute configuration (R). The process involves the hydrolysis of corresponding esterified derivatives in the presence of acids, starting from compounds of absolute configuration (S). The (R)-(I) products obtained are chiral synthons that are useful for producing enantiomerically pure drugs. Additionally, the preparation of (R)-carnitine is also included in this patent. Another notable patent involves nitriloxy derivatives of (R) and (S)-carnitine, further showcasing his expertise in the field.

Career Highlights

Throughout his career, Paolo De Witt has worked with notable companies, including Sigma-Tau Industrie Farmaceutiche Riunite S.p.a. and Sigma-Tau. His work has significantly impacted the pharmaceutical industry, particularly in the development of new drugs and compounds.

Collaborations

Paolo has collaborated with esteemed colleagues such as Maria Ornella Tinti and Roberto Castagnani, contributing to various projects and advancements in his field.

Conclusion

Paolo De Witt's innovative work and numerous patents highlight his significant role in advancing chemical processes and pharmaceutical development. His contributions continue to influence the industry and pave the way for future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…